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NEURONAVIGATED HIGH-FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC 
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CONTROLLED STUDY
Ivy K. Y. CHENG, BSc1, Karen M. K. CHAN, PhD1, Chun-sing WONG, MBChB2, Leonard S. W. LI, MBBS3, Karen M. Y. 
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Objective: There are potential benefits of repetitive 
transcranial magnetic stimulation (rTMS) in impro-
ving swallowing functions after stroke; however, 
few studies have been performed in the chronic 
stroke population. This study aims to distil the key 
effects of rTMS on swallowing functions and swallo-
wing-related quality of life.
Methods: Twenty-two participants with chronic post-
stroke dysphagia were randomly assigned into ac-
tive or sham rTMS groups. Seven participants with-
drew from the study, thus data from 15 participants 
(mean age 64.6 years) were analysed. Participants 
received 3,000 pulses of 5 Hz rTMS (active: n = 11; 
sham: n = 4) on the tongue area of the motor cor-
tex for 10 days over a period of 2 weeks. All partici-
pants were assessed 1 week before, and 2 months, 6 
months and 12 months after stimulation. Outcomes 
were measured by a videofluoroscopic swallowing 
study, swallowing-related quality-of-life questionn-
aire and Iowa Oral Performance Instrument.
Results: No statistically significant effects were 
identified for any outcome measures. 
Conclusion: This study indicates that 5 Hz rTMS app-
lied over the tongue area of the motor cortex is not 
effective for improving swallowing function in indi-
viduals with chronic post-stroke dysphagia. Possible 
explanations for these non-significant results are dis 
cussed. Future studies should explore the potential 
of the current protocol in conjunction with conven-
tional dysphagia therapy.
Key words: neurorehabilitation; dysphagia; repetitive trans-
cranial magnetic stimulation; stroke.
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Repetitive transcranial magnetic stimulation (rTMS) is a rapidly emerging neurorehabilitation 
technique. Studies have shown that rTMS can improve 
limb motor functions (1–3), language functions (4, 
5), and swallowing functions (6–12) after stroke. In 
this study, the effects of rTMS on the swallowing 
functions of individuals with chronic post-stroke 
dysphagia were investigated. Dysphagia is a common 
complication after stroke, the prevalence of which 
ranges from 41% to 78% (13–17). The quality of life 
of individuals with dysphagia is often hampered by 
discomfort and anxiety during eating, and by the need 
for special mealtime arrangements, which may hinder 
social interaction during mealtimes (18). Treatments 
that aim to restore or improve swallowing functions 
after stroke; for example, exercises for the swallowing 
muscles (19), are commonly used in clinical settings. 
However, these treatments require the active participa-
tion of patients and, as such, the efficacy of treatment 
depends largely on patient compliance. Individuals 
with cognitive impairments may find it difficult to 
follow the instructions.
rTMS has been proposed as an alternative post-
stroke dysphagia treatment. It is a non-invasive 
technique that modulates brain activity, and thereby 
induces physiological changes, using electromagnetic 
induction. An advantage of rTMS is that the patients 
do not need to be actively engaged during treatment, 
thus overcoming issues of patient compliance and the 
ability to understand instructions. Studies have shown 
that both high- (3 Hz and 5 Hz) and low- (1 Hz) fre-
quency rTMS can improve swallowing functions of 
acute, subacute and chronic stroke patients (6–9, 11, 
12). A previous study conducted by our team found 
preliminary evidence for using 10 sessions of 5 Hz 
rTMS applied to the tongue area of the motor cortex 
as a treatment for chronic post-stroke dysphagia (6). 
Although these studies showed therapeutic potential 
of rTMS in post-stroke dysphagia, stronger evidence 
is still needed to confirm its efficacy, especially for 
those with chronic (> 1 year) dysphagia.
The current study aimed to investigate the short- (2 
months) and long-term (6 and 12 months) effects of 
5 Hz rTMS on chronic post-stroke dysphagia. The 
stimulation target was determined based on 2 factors. 
Firstly, the tongue is important in transportation of 
food boluses during the oral phase of swallowing, 
and studies have shown that swallowing functions of 
post-stroke dysphagic individuals can be improved 
by improving tongue functions (20–22). Moreover, 
the affected hemisphere was stimulated based on the 
evidence that high-frequency rTMS (> 1 Hz) applied 
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citability and improve swallowing functions in stroke 
patients (7, 8). Therefore, the current study hypothe-
sized that by stimulating the tongue area of the motor 
cortex of the affected hemisphere using 5 Hz rTMS, 
tongue motor functions could be improved, and hence 
swallowing functions and swallowing-related quality 
of life may also be improved.
METHODS
This was a double-blinded, randomized controlled study. The 
participants and assessors were not aware of group assign-
ment. Data were collected from September 2013 to September 
2015. The study was approved by the ethics committee of the 
Institutional Review Board of the University of Hong Kong/
Hospital Authority Hong Kong West Cluster (reference number: 
UW 14-193). Signed informed consent was obtained from all 
participants prior to data collection.
Trial registration
The study was registered with the HKU Clinical Registry 
(Identifier: HKUCTR-1868). 
Participants
Inclusion criteria were: presence of post-stroke dysphagia for 
at least 12 months; adequate cognitive ability to follow simple 
instructions; aged below 80 years; and able to sit upright for 
at least 30 min. Exclusion criteria included: previous history 
and/or family history of epilepsy; history of head injury or 
neurological disease other than stroke; neurosurgery; oral and 
maxillofacial surgery; dysphagia prior to stroke; presence of 
magnetic implants inside the body; and medically unstable 
and on medications that lower the neural threshold (23). All 
participants were randomly assigned to the active rTMS group 
or the sham rTMS group using a randomly-generated sequence. 
Each participant underwent magnetic resonance imaging (MRI) 
of the brain before stimulation. The site of brain lesions was 
confirmed by a radiologist (author WCS) (Table I). 
Obtaining resting motor threshold
Before the first rTMS session, the resting motor threshold 
(RMT) of each participant was obtained to determine the 
stimulation intensity. The motor evoked potentials (MEPs) of 
the tongue were recorded using 2 silver/silver chloride elec-
trodes mounted on a mouthpiece, which were connected to the 
built-in of the BrainsightTM neuronavigation system (Rogue 
Research Inc., Montreal, Canada). The electrodes were placed 
on the surface of the tongue contralateral to the stimulation 
side. Single TMS pulses were delivered onto the tongue area 
of motor cortex to elicit MEPs from the tongue. The RMT was 
defined as the minimum stimulus intensity required to elicit 5 
responses of 50 μV or above in 10 consecutive trials (50% suc-
cessful MEPs) (23). Once the stimulation site was identified, 
the site was marked onto the participant’s MRI scan using the 
neuronavigation system.
Repetitive transcranial magnetic stimulation (rTMS)
The experimental group received 30 100-pulse trains of 5 Hz 
rTMS, with inter-train interval of 15 s, per day for 10 days 
over 2 weeks.
Biphasic rTMS pulses were delivered through a 70-mm 
Double Air Film coil (Magstim®, Whitland, UK) attached 
to a Magstim Rapid2 (Magstim®). rTMS was applied at 90% 
RMT over the tongue area of the motor cortex of the affected 
hemisphere, as identified and retrieved from the previous MEP 
session using the neuronavigation system (Table I). For partici-
pants with bilateral lesion, the left hemisphere was stimulated 
due to left hemispheric dominance for swallowing (24). The 
sham group received sham rTMS via a 70-mm Double Air Film 
sham coil (Magstim®), which had an identical appearance and 
noise as the real coil, but does not deliver active stimulation 
of deep nerves. The stimulation schedules were identical for 
both groups.
Outcome measurements
All participants were assessed at 4 time-points: 1 week before 
stimulation, 2, 6 and 12 months after stimulation. The evaluation 
of outcomes was performed using: (i) videofluroscopic swal-
lowing study (VFSS); (ii) a swallowing-related quality of life 
Table I. Participants’ demographics and repetitive transcranial magnetic stimulation (rTMS) intensity
Group assignment Participant ID Sex Site of lesion Age (years)
Time post-stroke 
(months)
Stimulation intensity (% of 
maximum stimulator output)
Active 1 M Left temporal 66 69 66
2 M Right pons 74 75 59
3 F Bilateral periventricular white matter 66 20 54
4 F Left corona radiata 56 56 41
5 M Bilateral periventricular white matter 65 42 63
6 F Right basal ganglia 75 22 50
7 M Left parietal 53 41 54
8 F Right thalamus 69 19 57
9 M Left pons 51 24 75
10 M Bilateral periventricular white matter 69 42 45
11 M Brainstem and left cerebellar 72 56 72
Mean (SD) 65.1 (8.3) 42.4 (19.9)
Sham 12 M Bilateral basal ganglia 70 77 68
13 M Bilateral subcortical white matter 65 35 59
14 M Right occipital 66 25 63
15 M Right parietal 52 22 60
Mean (SD) 63.3 (7.8) 39.8 25.4)










































477rTMS for chronic post-stroke dysphagia
questionnaire; and (iii) maximum tongue strength 
measurement at each assessment time.
Videofluroscopic swallowing study (VFSS). Partici-
pants were asked to swallow 3 trials of 5 ml of each of 
the following: thin, mildly-thick and extremely-thick 
fluid. The barium sulphate (8.7% w/v, E-Z-Paque®, 
E-Z-EM, New York, USA) liquid was first prepared 
and then thickened to different consistencies using 
thickener (ThickenUp®, Nestle, Lutry, Switzerland). 
The swallowing process was recorded and then 
quantitatively analysed in terms of: (i) oral transit 
time; (ii) stage transit time; (iii) pharyngeal transit 
time; (iv) amount of post-swallow residue in valle-
culae (normalized residue ratio scale; NRRSv); and 
(v) in piriform sinus (NRRSps); and (vi) pharyngeal 
constriction ratio. The VFSS was digitally recorded 
at a frame-rate of 30 frames/s.
The software program ImageJ (National Institute of 
Health) was used to perform frame-by-frame analysis 
and spatial measurements on VFSS videos. All measu-
res were obtained from lateral views. Appendix I shows 
the definitions of the VFSS measures. 
Swallowing-related quality of life questionnaire. The 
Swallowing Activity and Participation Profile (SAPP) 
was used to evaluate the swallowing-related quality of 
life of the participants. The SAPP was developed under the In-
ternational Classification of Functioning, Disability and Health 
(ICF; World Health Organization) framework (25), consisting of 
38 items grouped into swallowing impairment, personal, social 
and emotional subscales. The higher the SAPP total scores, the 
poorer the swallowing-related quality of life.
Maximum tongue strength. The maximum tongue strength of 
each participant was measured using the Iowa Oral Performance 
Instrument (IOPI; IOPI Medical LLC, Washington, USA). 
Participants were asked to use the tongue to press the air-filled 
IOPI tongue bulb against the hard palate 3 times using maximal 
strength. The maximum tongue pressure among the 3 trials was 
recorded as the maximum tongue strength.
Statistical analysis
The oral transit time, stage transit time, pharyngeal transit 
time and pharyngeal constriction ratio for all consistencies, 
and NRRSv and NRRSps for extremely-thick fluid, the total 
SAPP scores and maximum tongue strength were analysed 
using general linear mixed model (GLMM) to compare the 
between-group and across-time differences. The GLMM was 
used because it was designed to account for a wide variability 
of data, which is common in experimental, longitudinal studies 
and can accommodate for missing and unbalanced data (26). 
RESULTS
Fig. 1 shows the flow diagram for participant recru-
itment. Participants were openly recruited from the 
public and through a rehabilitation hospital. Fifty-eight 
individuals were screened face-to-face and/or via 
phone interview for eligibility for the study. Twenty-
two subjects met the inclusion and exclusion criteria 
and joined the study. They were randomly allocated 
into active or sham groups. Five of participants in the 
sham group withdrew before rTMS sessions for per-
sonal reasons and unstable medical conditions. Upon 
completion of the 10 rTMS sessions, 2 participants in 
the sham group did not return after the first follow-up. 
One participant in the active group did not return for 
the 12 months post-rTMS follow-up assessment. A 
final total of 14 participants completed all follow-ups. 
In the current study, the data from15 participants (11 
males, 4 females; mean age 64.5 years), including the 
one who did not return for the final follow-up, were 
analysed. Table I shows the demographic information 
for the participants.
All participants received 10 sessions of rTMS (active 
or sham) with no reports of discomfort. There was 
no significant difference between the groups in age 
(p = 0.706) or post-stroke duration (p = 0.861).
Videofluoroscopic swallowing study (VFSS) 
The VFSS videos were analysed by a speech therapist 
(author CKYI) blinded to the group assignment. Since 
53% of the participants in the current study showed 
pharyngeal residue after swallowing extremely-thick 
fluid, but not the other consistencies, the analysis of 
such residue focused only on extremely-thick fluid 
consistency. Lower NRRSv and NRRSps values in-
dicated less pharyngeal residue. A lower pharyngeal 
constriction ratio indicated a larger maximum pha-
ryngeal constriction. 
Tables II–VII present the results of VFSS measures. 
Significant main effects for time were found in: (i) oral 
transit time for mildly-thick and extremely-thick fluid; 
(ii) stage transit time; (iii) pharyngeal transit time for 
all consistencies; and (iv) NRRSps for extremely-thick 
Fig. 1. Flow of participants in the study according to the Consolidated Standards 
of Reporting Trials (CONSORT) statement. rTMS; repetitive transcranial magnetic 
stimulation.
 Assessed for eligibility (n=58) 
Excluded due to not meeting inclusion 
criteria (n=36) 
 
Analysed (n=11; n=10 for the last 
follow-up) 
$
Lost to follow-up (n=1)  
(reason: unstable health condition 
before the last follow-up) 
 
Received active rTMS intervention (n=11) 
$
Lost to follow-up (n=2)  
(reasons: unstable health condition and 
unwilling to continue follow ups)  






Allocated to active rTMS group (n=14) 
$
Allocated to sham rTMS group (n=8) 
$
Allocation
Withdrew due to personal 
reasons and unstable 
medical conditions (n=2) 
 
Reveived rTMS
Withdrew due to personal 
reasons and unstable 
medical conditions (n=3) 
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DISCUSSION
This study found no significant treatment effects of 5 
Hz rTMS on swallowing function, tongue strength or 
swallowing-related quality of life in patients with ch-
ronic post-stroke dysphagia. All participants completed 
the entire rTMS protocol with no reports of discomfort 
or adverse reactions, suggesting that 10 days of 5 Hz 
rTMS applied over 2 weeks is safe and tolerable. 
fluid. All of the above-mentioned timing measures 
increased after rTMS, whereas NRRSps decreased 
after rTMS. However, no significant main effects for 
group or interaction effects between group and time 
were found for all measures. 
Swallowing Activity and Participation Profile (SAPP)
The total SAPP scores of both groups were calculated 
(Table VIII). No significant main effects or interaction 
effects for groups and time were found for the total 
SAPP scores. 
Maximum tongue strength
No significant main effects or interaction effects for 
groups and time were found for the maximum tongue 
pressure (Table IX). 
Table II. Descriptive statistics for videofluroscopic swallowing 
















Active 0.97 (0.33) 0.98 (0.16) 1.37 (0.26) 1.37 (0.34)
Sham 0.54 (0.29) 1.46 (0.68) 0.59 (0.17) 0.90 (0.19)
Stage transit 
time, s
Active 0.65 (0.12) 0.99 (0.16) 1.05 (0.27) 1.48 (0.32)
Sham 0.43 (0.11) 1.09 (0.38) 1.18 (0.45) 1.02 (0.17)
Pharyngeal 
transit time, s
Active 1.04 (0.19) 1.32 (0.18) 1.39 (0.32) 1.90 (0.36)




Active 0.04 (0.01) 0.03 (0.01) 0.02 (0.00) 0.03 (0.01)
Sham 0.02 (0.01) 0.02 (0.00) 0.01 (0.00) 0.01 (0.00)
SD: standard deviation.
Table III. General Linear Mixed Model results of the videofluroscopic 
swallowing study (VFSS) measures for thin liquid
VFSS measures




Oral transit time, s F(3, 11.7) = 1.610 
p = 0.240
F(1, 13.0) = 0.253 
p = 0.532
Stage transit time, s F(3, 8.8) = 8.134
*p = 0.007
F(1, 12.0) = 0.539
p = 0.477
Pharyngeal transit time, s F(3, 8.4) = 6.425
*p = 0.014
F(1, 12.2) = 0.756
p = 0.401
Pharyngeal constriction ratio F(3, 12.7) = 0.666
p = 0.588
F(1, 12.5) = 3.813
p = 0.074
*p < 0.05.
Table IV. Descriptive statistics for videofluoroscopic swallowing 
















Active 0.77(0.17) 1.14 (0.13) 1.82 (0.40) 1.89 (0.41)
Sham 0.69 (0.19) 1.64 (0.57) 1.20 (0.42) 0.99 (0.30)
Stage transit 
time, s
Active 1.07 (0.29) 1.28 (0.24) 1.78 (0.55) 1.84 (0.58)
Sham 1.07 (0.50) 2.09 (0.83) 1.81 (0.80) 1.51 (0.71)
Pharyngeal 
transit time, s
Active 1.38 (0.30) 1.65 (0.27) 2.15 (0.57) 2.31 (0.60)




Active 0.05 (0.01) 0.08 (0.03) 0.04 (0.00) 0.04 (0.01)
Sham 0.04 (0.02) 0.05 (0.01) 0.02 (0.00) 0.02 (0.00)
SD: standard deviation.
Table V. Generalized Linear Mixed Model results of the 







Oral transit time, s F(3, 12.7) = 7.710 
*p = 0.003
F(1,13.0) = 0.720 
p = 0.411
Stage transit time, s F(3, 12.8) = 3.720
*p = 0.040
F(1, 13.0) = 0.007
p = 0.933
Pharyngeal transit time, s F(3, 12.8) = 5.009
*p = 0.016
F(1, 13.0) = 0.002
p = 0.890
Pharyngeal constriction ratio F(3, 12.4) = 1.562
p = 0.248
F(1, 12.9) = 1.279
p = 0.279
*p < 0.05.
Table VI. Descriptive statistics for videofluoroscopic swallowing 
















Active 1.01 (0.45) 1.49 (0.79) 1.95 (1.37) 2.18 (1.49)
Sham 0.85 (0.29) 2.08 (1.02) 2.77 (2.29) 1.64 (0.83)
Stage transit 
time, s
Active 1.21 (1.29) 3.11 (2.99) 2.71 (3.61) 2.35 (1.39)
Sham 1.27 (1.13) 3.12 (2.97) 1.92 (1.59) 2.34 (1.28)
Pharyngeal 
transit time, s
Active 1.58 (1.38) 2.88 (2.54) 3.13 (3.73) 2.84 (1.52)
Sham 1.64 (1.14) 3.62 (3.16) 2.31 (1.70) 2.71 (1.29)
+NRRSv Active 0.19 (0.42) 0.15 (0.27) 0.03 (0.09) 0.13 (0.27)
Sham 0.08 (0.11) 0.16 (0.17) 0.08 (0.12) 0.08 (0.14)
+NRRSps Active 0.21 (0.46) 0.07 (0.12) 0.04 (0.09) 0.11 (0.25)




Active 0.06 (0.05) 0.05 (0.04) 0.04 (0.02) 0.05 (0.04)
Sham 0.03 (0.02) 0.04 (0.01) 0.02 (0.01) 0.03 (0.01)
+NRRSv: normalized residue ratio scale for valleculae residue; NRRSps: 
normalized residue ratio scale for piriform sinus residue; SD: standard deviation.
Table VII. Generalized Linear Mixed Model results of the 





Significance level for 
groups
Oral transit time, s F(3, 12.6) = 6.01 
*p = 0.009
F(1, 13.1) = 1.149 
p = 0.706
Stage transit time, s F(3, 12.9) = 7.261
*p = 0.004
F(1, 13.0) = 0.025
p = 0.877
Pharyngeal transit time, s F(3, 12.8) = 8.758
*p = 0.002
F(1, 13.0) = 0.000
p = 0.984
+NRRSv F(3, 13.0) = 1.226
p = 0.340
F(1, 13.0) = 0.034
p = 0.856
+NRRSps F(3, 13.0) = 3.427
p = 0.049
F(1, 13.0) = 0.900
p = 0.360
Pharyngeal constriction ratio F(3, 12.9) = 1.333
p = 0.307
F(1, 13.0) = 0.804
p = 0.386
*p < 0.05.
+NRRSv: normalized residue ratio scale for valleculae residue; NRRSps: 
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There are several possible explanations for these 
negative results. First, the stimulation protocol may 
not be optimized for increasing cortical excitability 
and inducing improvement in swallowing function of 
the participants. A recent systematic review by Pisegna 
et al. (27) suggested that non-invasive stimulation of 
the unaffected hemisphere may be more effective in 
improving swallowing functions after stroke. Further 
investigations on the changes in cortical excitability of 
tongue motor cortex after rTMS may provide insights 
into the optimization of stimulation protocol.
Secondly, the VFSS protocol, which used a bolus 
volume of 5 ml for all swallowing trials, may not be 
sensitive enough to detect the breakdown level of the 
patients. Dantas et al. found that larger bolus volume 
requires adaptation of swallowing structure movements, 
which might be more difficult for some patients (28). 
The third explanation relates to patient selection. 
Since most of the participants have mild to moderate 
dysphagia, the room for extensive improvements may 
be small. The effects of the current rTMS protocol on 
individuals with more severe dysphagia are unknown. 
Finally, the current protocol failed to increase tongue 
strength, suggesting that cortical stimulation alone 
may not be sufficient. Pairing rTMS with tongue or 
swallowing exercises may bring about more significant 
improvements. A study by Koganemaru et al. (29) 
suggested that improvement in grip strength may be 
best achieved with a combination of rTMS and use-
dependent exercises in the chronic stroke population. 
Moreover, Dejaeger et al. (30) suggested that the de-
gree of tongue-driving force affects clearance of pha-
ryngeal residue. Through improving tongue strength, 
the clearance of pharyngeal residue after swallow may 
be more efficient.
The current study is limited by a small sample 
and unbalanced group sizes. Individual variations in 
swallowing functions may have masked any changes 
subsequent to rTMS. Future studies may adopt a block 
randomization process in order to balance group sizes. 
Table VIII. Descriptive statistics and Generalized Linear Mixed Model results in total Swallowing Activity and Participation Profile scores 
Baseline 
Mean (SD)
2 months follow-up 
Mean (SD)
6 months follow-up 
Mean (SD)
12 months follow-up 
Mean (SD)
Significance level for 
time
Significance level for 
groups
Active 111.1 (61.9) 83.1 (52.4) 80.2 (51.1) 74.1 (47.3) F(3, 13) = 0.813 
p = 0.509
F(1, 13) = 1.397 
p = 0.258Sham 57.8 (24.2) 51.0 (32.6) 56.3 (44.2) 65.3 (39.6)
SD: standard deviation.
Table IX. Descriptive statistics and Generalized Linear Mixed Model results of maximum tongue pressure (kPa) 
Baseline 
Mean (SD)
2 months follow-up 
Mean (SD)
6 months follow-up 
Mean (SD)
12 months follow-up 
Mean (SD)
Significance level for 
time
Significance level for 
groups
Active 32.0 (17.4) 32.1 (14.9) 28.9 (15.2) 34.1 (14.6) F(3, 9.3) = 0.419 
p = 0.744
F(1, 13) = 0.595 
p = 0.455Sham 34.0 (19.3) 41.3 (27.3) 42.0 (24.6) 37.5 (19.9)
SD: standard deviation.
The recruitment of participants was of great challenge 
because most patients with chronic post-stroke dyspha-
gia have other comorbidities; for example, dementia, 
history of epilepsy, bed-bound or unstable health condi-
tion, which may be counter-indicators for rTMS studies. 
In conclusion, the current study indicated that 5 Hz 
rTMS applied over the tongue area of the motor cortex 
for 10 days was not effective in improving swallowing 
function in patients with chronic post-stroke dyspha-
gia. However, given the limitations of the small and 
unbalanced group sizes in this study, the therapeutic 
effects of the current protocol remain uncertain. Future 
studies are needed that include patients with more 
severe dysphagia and balanced group sizes to study 
the effects of the current protocol in conjunction with 
swallowing exercises. 
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Appendix I. Definitions of videofluoroscopic swallowing study measures
Duration measures
The definitions of the duration measures used in the current study were adapted from the Oropharyngeal Swallow Efficiency (31, 32):
1. Oral transit time is defined as the duration (in s) between the onset of bolus movement in the oral cavity and the arrival of the bolus head at the junction of 
the lower rim of the mandible and the tongue base. 
2. Stage transit time is defined as the duration (in s) between the arrival of the bolus head at the junction of the lower rim of the mandible and the tongue base 
and the first laryngeal elevation. 
3. Pharyngeal transit time is defined as the duration (in s) between the first laryngeal elevation and the restoration of upper oesophageal sphincter constriction 
after passage of bolus through the cricopharyngeal area.
Pharyngeal constriction ratio
The pharyngeal area at the hold position (PAhold), where the bolus was held in the oral cavity before backward propulsion, and the pharyngeal area at maximum 
constriction position (PAmax) were measured as described in the study by Leonard and colleagues (33, 34) and recorded in cm
2. The pharyngeal constriction ratio 
is defined as PAmax/PAhold.
Amount of post-swallow residue in valleculae and piriform sinus
The areas of the valleculae and piriform sinus and the residue in these 2 areas after the first swallow were measured. The normalized residue ratio scale (NRRS) 
(35) was calculated for vallecular (NRRSv) and piriform sinus (NRRSps) residue to estimate the amount of post-swallow residue. The NRRS is a recently developed 
pixel-based measurement that aims to provide a more objective and quantifiable judgment on the amount of pharyngeal residue (35, 36). 
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